Q32 Bio will present new bempikibart data in alopecia areata at EADV2026 on Sept. 30, including 36-week results from SIGNAL AA Part B. The update also includes initial 16-week off-drug findings as the company moves toward registration-directed development.
published
Q32 Bio will present new bempikibart data in alopecia areata at EADV2026 on Sept. 30, including 36-week results from SIGNAL AA Part B. The update also includes initial 16-week off-drug findings as the company moves toward registration-directed development.
Latest documented BWB result
$APP market result
Exit $APP Sold Puts for a nice profit and then sold more Puts - this time the $325's for $3.97
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.